Influenza A/B and SARS-CoV-2 Multiplex Assay

BPHL has verified the FDA, EUA, approved a qualitative real time reverse transcription polymerase chain reaction (rRT-PCR) influenza A/B and SARS-CoV-2 multiplex assay utilizing the CDC protocol to detect the Influenza A/B and SARS-CoV-2 viruses.